{"pageContent": "Purpose of review: Men with high-risk germline mutations are at significantly higher risk of developing and dying from prostate cancer. Current screening and treatment paradigms may lead to missed opportunities for cure. Herein we review the current literature on prevention, screening and treatment of these carriers and explore the potential role of prophylactic prostatectomy in primary prevention of prostate cancer mortality.", "metaData": {"source": "[Clinical analysis of 1,000 patients with prostate cancer]\nhttps://pubmed.ncbi.nlm.nih.gov/16613161/"}}